Literature DB >> 15480781

Basement membrane proteins play an active role in the invasive process of human hepatocellular carcinoma cells with high metastasis potential.

Bo Tian1, Yan Li, Xue-Ning Ji, Jie Chen, Qiong Xue, Sheng-Long Ye, Yin-Kun Liu, Zhao-You Tang.   

Abstract

PURPOSE: Cell-matrix adhesive interaction has an important role in the invasive process of tumor cells, and integrins are the major receptors mediating cell-matrix adhesion. The current study is to investigate the modulation of basement membrane (BM) proteins, especially collagen IV (C IV), laminin (LN), and fibronectin (FN) in the invasive processes of human hepatocellular carcinoma (HCC) cells in vitro, and to reveal the roles of beta1 integrins and RGD-containing oligopeptide in the cell-matrix interaction.
METHODS: Static adhesion assay was performed to study the rates of adhesion of MHCC97-H cells, treated or untreated with anti-beta1 (2 microg ml(-1)) and GRGDS, to C IV (50 microg ml(-1)), LN (50 microg ml(-1)) or FN (50 microg ml(-1)). Gelatin zymography was used to detect the secretion of MMPs in the conditioned medium of MHCC97-H cells incubated 24 h by C IV, LN or FN, and interactions with anti-beta1 and GRGDS. Transwell chamber assay was used to investigate the influence of C IV, LN or FN, interacting with anti-beta1 and GRGDS, on the cellular mobility of MHCC97-H cells.
RESULTS: Compared with blank control group, MHCC97-H cells showed significantly higher rates of adhesion to C IV, LN, and FN. Pretreatment with anti-beta1 could suppress adhesion to C IV, LN or FN, but GRGDS inhibited adhesion to FN (P<0.05) only. LN and FN could stimulate the secretion of MMPs by MHCC97-H cells cultured in vitro, especially MMP-9 and its activated type. Treatment with anti-beta1 could partly counteract the effects of LN and FN. GRGDS could prominently induce the secretion of MMPs, but the effect could be inhibited by pretreatment of anti-beta1. The results of Transwell chamber assay showed that LN, FN, and GRGDS could increase the number of tumor cells penetrating the microporous membrane, but the data of C IV did not reach significance. The effects were partly counteracted by anti-beta1.
CONCLUSION: BM proteins play an active role in the invasive process of human hepatocellular carcinoma cells. Integrin beta1 is an important molecule which mediates the cell-matrix adhesive interaction of tumor cells. RGD-containing peptides competitively combine with the binding site of integrin beta1, and the effects of FN are RGD sequence-dependent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15480781     DOI: 10.1007/s00432-004-0614-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  31 in total

Review 1.  Role of basement membrane in tumor growth and metastasis.

Authors:  H K Kleinman; J Koblinski; S Lee; J Engbring
Journal:  Surg Oncol Clin N Am       Date:  2001-04       Impact factor: 3.495

Review 2.  Integrin adhesion receptors in tumor metastasis.

Authors:  Brunhilde Felding-Habermann
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

3.  Recognition in cell adhesion. A comparative study of the conformations of RGD-containing peptides by Monte Carlo and NMR methods.

Authors:  R E Cachau; E H Serpersu; A S Mildvan; J T August; L M Amzel
Journal:  J Mol Recognit       Date:  1989-12       Impact factor: 2.137

4.  Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.

Authors:  Y Li; Z Y Tang; S L Ye; Y K Liu; J Chen; Q Xue; J Chen; D M Gao; W H Bao
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

5.  Oral cancer: role of the basement membrane in invasion.

Authors:  D F Wilson; D J Jiang; A M Pierce; O W Wiebkin
Journal:  Aust Dent J       Date:  1999-06       Impact factor: 2.291

6.  Expression of the integrin alpha5 subunit and its mediated cell adhesion in hepatocellular carcinoma.

Authors:  M Yao; X D Zhou; X L Zha; D R Shi; J Fu; J Y He; H F Lu; Z Y Tang
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

7.  Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment.

Authors:  Changqing Yang; Michael Zeisberg; Julie C Lively; Pia Nyberg; Nezam Afdhal; Raghu Kalluri
Journal:  Cancer Res       Date:  2003-12-01       Impact factor: 12.701

Review 8.  Multi-step cascade of tumor cell metastasis.

Authors:  M L Stracke; L A Liotta
Journal:  In Vivo       Date:  1992 Jul-Aug       Impact factor: 2.155

9.  Differential expression of transforming growth factor alpha, adhesions molecules and integrins in primary, metastatic liver tumors and in liver cirrhosis.

Authors:  K Jaskiewicz; M R Chasen
Journal:  Anticancer Res       Date:  1995 Mar-Apr       Impact factor: 2.480

10.  There is binding of collagen IV to beta 1 integrin during early skin basement membrane assembly.

Authors:  R Fleischmajer; J S Perlish; E D MacDonald; A Schechter; A D Murdoch; R V Iozzo; Y Yamada
Journal:  Ann N Y Acad Sci       Date:  1998-10-23       Impact factor: 5.691

View more
  12 in total

1.  A three-dimensional cell biology model of human hepatocellular carcinoma in vitro.

Authors:  Jianhua Tang; Jiefeng Cui; Rongxin Chen; Kun Guo; Xiaonan Kang; Yan Li; Dongmei Gao; Lu Sun; Changde Xu; Jie Chen; Zhaoyou Tang; Yinkun Liu
Journal:  Tumour Biol       Date:  2010-12-08

2.  Oncolytic adenovirus SG600-IL24 selectively kills hepatocellular carcinoma cell lines.

Authors:  Xin-Bo Xue; Chao-Wen Xiao; Hui Zhang; Ai-Guo Lu; Wei Gao; Zhu-Qing Zhou; Xin-Lai Guo; Ming-An Zhong; Yao Yang; Cong-Jun Wang
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

3.  3D tumour models: novel in vitro approaches to cancer studies.

Authors:  Agata Nyga; Umber Cheema; Marilena Loizidou
Journal:  J Cell Commun Signal       Date:  2011-04-16       Impact factor: 5.782

4.  Lowered HGK expression inhibits cell invasion and adhesion in hepatocellular carcinoma cell line HepG2.

Authors:  Su-Xia Han; Qing Zhu; Jin-Lu Ma; Jing Zhao; Chen Huang; Xi Jia; Dan Zhang
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

5.  Notch2 regulates matrix metallopeptidase 9 via PI3K/AKT signaling in human gastric carcinoma cell MKN-45.

Authors:  Ling-Yun Guo; Yu-Min Li; Liang Qiao; Tao Liu; Yuan-Yuan Du; Jun-Qiang Zhang; Wen-Ting He; Yong-Xun Zhao; Dong-Qiang He
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

6.  Integrins as antimetastatic targets of RGD-independent snake venom components in liver metastasis [corrected].

Authors:  Felix Rosenow; Rainer Ossig; Dorit Thormeyer; Peter Gasmann; Kerstin Schlüter; Georg Brunner; Jörg Haier; Johannes A Eble
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

7.  Extracellular matrix protein-coated scaffolds promote the reversal of diabetes after extrahepatic islet transplantation.

Authors:  David M Salvay; Christopher B Rives; Xiaomin Zhang; Fei Chen; Dixon B Kaufman; William L Lowe; Lonnie D Shea
Journal:  Transplantation       Date:  2008-05-27       Impact factor: 4.939

8.  A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma.

Authors:  Raghothama Chaerkady; H C Harsha; Anuradha Nalli; Marjan Gucek; Perumal Vivekanandan; Javed Akhtar; Robert N Cole; Jessica Simmers; Richard D Schulick; Sujay Singh; Michael Torbenson; Akhilesh Pandey; Paul J Thuluvath
Journal:  J Proteome Res       Date:  2008-08-21       Impact factor: 4.466

9.  The interaction of HAb18G/CD147 with integrin alpha6beta1 and its implications for the invasion potential of human hepatoma cells.

Authors:  Jing-yao Dai; Ke-feng Dou; Cong-hua Wang; Pu Zhao; Wayne Bond Lau; Ling Tao; Ya-mei Wu; Juan Tang; Jian-li Jiang; Zhi-nan Chen
Journal:  BMC Cancer       Date:  2009-09-23       Impact factor: 4.430

10.  Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma.

Authors:  Cong-Jun Wang; Chao-Wen Xiao; Tian-Geng You; Ya-Xin Zheng; Wei Gao; Zhu-Qing Zhou; Jun Chen; Xin-Bo Xue; Jia Fan; Hui Zhang
Journal:  Mol Cancer       Date:  2012-05-08       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.